Table 5.
CKD stage | Total | Male | Female | |||
---|---|---|---|---|---|---|
n | eGFR decline/year (mL/min/1.73 m2/year) | n | eGFR decline/year (mL/min/1.73 m2/year) | n | eGFR decline/years (mL/min/1.73 m2/years) | |
3a | 352 | 1.97 ± 4.00 | 214 | 2.58 ± 4.53 | 138 | 1.03 ± 2.74‡ |
3b | 230 | 2.15 ± 3.49 | 147 | 2.42 ± 3.60 | 83 | 1.66 ± 3.24 |
4 | 188 | 3.48 ± 3.60***,†† | 120 | 3.79 ± 3.48*,† | 68 | 2.93 ± 3.77***,† |
* p < 0.05, *** p < 0.001 vs. CKD stage 3a; † p < 0.05, †† p < 0.01 vs. CKD stage 3b (ANOVA, Tukey post hoc test)
‡ p < 0.001 vs. male by unpaired t test